CONVINCE (COVID New Vaccine Information, Communication and Engagement)

Overview

CONVINCE was a Call to Action from Wilton Park, City University of New York (CUNY) Graduate School of Public Health & Health Policy and the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine.

The initiative was inspired by the need for effective communication to prepare a ‘vaccine literate’ public and persuade policymakers to trust the science and embrace new vaccines for COVID-19 as they become available.

CONVINCE argued for investment in the following areas, to help ensure COVID-19 vaccines are accepted:

  • a multi-sectoral commitment to develop trust in vaccines;
  • preparation of accurate and convincing information sources about vaccines;
  • innovative multi-media and interpersonal approaches to communicate and engage with all audiences.

What CONVINCE did:

  • Convened local and global experts in policy, health, academia, private sector, NGOs, civil society, and communications to create a ‘whole-of-society’ approach
  • Connected & catalyzed action along each step of the vaccine journey
  • Communicated with a global audience by sharing quality-controlled, multi-media messaging adapted to meet local contexts

Business Partners to CONVINCE

After launch, CONVINCE developed into a novel multi-sector initiative to inoculate society against COVID-19 by empowering a “vaccine literate” public to sustain ”community immunity” against coronavirus infection. As indicated in the press release and further articulated on the USCIB website, the CONVINCE business coalition leveraged USCIB’s extensive global network of leading international business organisations and multinational corporations to promote vaccine literacy and uptake with large employers and small and medium-sized enterprises (SMEs) worldwide.

To put this process in motion, Wilton Park, City University of New York (CUNY) Graduate School of Public Health and Health Policy, and the Vaccine Confidence Project™ convened and facilitated candid dialogue designed to elicit the broadest range of options from diverse stakeholders to determine how best to advance a ‘coronavirus-protected’ population – beginning with effective, measurable communications to advance public understanding of vaccination to protect our lives and livelihoods.